Lazard Asset Management LLC Jounce Therapeutics, Inc. Transaction History

Lazard Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$7.11 - $9.64 $85,995 - $116,595	-12,095 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.04 - $8.73 $60,958 - $105,589	12,095 New	12,095 $89,000
Q2 2021 Aug 12, 2021	SELL	$6.58 - $10.66 $35,880 - $58,128	-5,453 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$6.73 - $13.87 $36,698 - $75,633	5,453 New	5,453 $56,000
Q1 2020 May 14, 2020	SELL	$2.91 - $8.7 $1,469 - $4,393	-505 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.81 - $9.21 $1,419 - $4,651	505 New	505 $4,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.